Who was Barbara Mitchell?
  1. Search
  2. John R. Graham
  3. Site

Search

Search results

  1. Advertising Prescription Drugs Benefits American Patients

      One difference between Canadian and American health care is that the US government allows research-based drug makers to advertise the benefits of their medicines to patients, but the Canadian government outlaws this freedom of speech. Unfortunately, the ...

  2. Ban Online Pharmacies

    Appeared in the Winnipeg Free Press The government of Manitoba has embarked on an ill-advised industrial policy that will not only put Canadians’ health at risk without improving employment or economic growth in the province, but also violates the ...

  3. Prescription Drug Prices in Canada and the United States, Part 4: Canadian Prescriptions for American Patients Are Not the Solution

    This paper looks at the cross-border mail-order pharmaceutical trade and determines that it suffers serious flaws. https://www.fraserinstitute.org/sites/default/files/CanadianPrescriptionsforAmericans.pdf ...

  4. Advertising Prescription Drugs Will Benefit Canadians

    Appeared in the Sentinel-Review According to the Canadian Medical Association Journal, our government should continue to prohibit research-based drug makers from communicating with patients through direct-to-consumer advertising (DTCA). A survey reported ...

  5. Briefing to the House of Commons Standing Committee on Health on Prescription Drugs

    The Canadian government needs to abolish pharmaceutical price controls, increase competition amongst drug makers by allowing advertising, stop the gray market in prescription drugs from Canada to the United States, and take other steps to improve ...

  6. Overhead, So What? Medicare Needs Competition

    Appeared in The Globe and Mail, August 25, 2003 Last Thursday, the New England Journal of Medicine published an article claiming that administrative costs of health care in the United States are higher than in those in Canada: $1,059 (US) in the United ...

  7. Myths of Pharmaceutical Patents

    Appeared in the Ottawa Citizen Before breaking for the summer, the House of Commons Standing Committee on Industry, Science, and Technology considered weakening the patent regulations that support Canada’s pharmaceutical market. Now, prompted by public ...

  8. Our Anti-Model to the North: Whatever You Do: Don't Do Like Canada

    Appeared in the National Review On-line, June 23, 2003 Twelve years ago, Canadians were scandalized to learn that a Toronto hospital was using its CT scanner to do brain examinations on dogs for $300 (Cdn.) a pop. Meanwhile, patients were waiting up to ...

  9. Prescription Benefit Tied to Medicare may Deny Payments for Pricier, More Effective Drugs

    Appeared in the Watertown (NY) Daily Times and the Norwalk (CT) Hour Worried about rising expenditures for prescription drugs, many states are employing preferred lists to encourage doctors to prescribe older, lower-priced drugs and forego the latest, ...

  10. Drug Disincentives

    Appeared in the National Post In January, GlaxoSmithKline, a global pharmaceutical manufacturer, announced that it would stop delivering its prescription drugs to wholesalers that supply Canadian mail order pharmacies that sell to American patients. These ...